Hanmi Pharm’s ‘Amosartan,’ the hottest seller among improved drugs
Among improved drugs developed by pharmaceutical companies, the hottest seller was observed to be ‘Amosartan,’ a Hanmi Pharm’s hypertension treatment.
‘Amosartan,’ which approved on March 2009, recorded KRW 387.7 billion sales by the first half.
According to the Ministry of Food and Drug Safety...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
